Xiong-Zhi Wu

Prof. Xiong-Zhi Wu


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2007 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
XWXiong-Zhi Wu
Xiong-Zhi Wu
GXGuang‐Ru Xie
Guang‐Ru Xie
DCDan Chen
Dan Chen
Hypoxia enhances proliferation, angiogenesis, metastasis, chemoresistance, and radioresistance of hepatocellular carcinoma (HCC); suppresses differentiation and apoptosis of HCC; and consequently leads to resistance of transarterial embolization (with or without chemotherapy). Because transarterial embolization contributes to angiogenesis via inducing hypoxia, therapy combined with transarterial embolization and antiangiogenic therapy provides a new strategy for the treatment of HCC. Unfortunately, hypoxia leads to the escape of HCC cells from transarterial embolization and antiangiogenic therapy. Thus combined therapy that induces and targets hypoxia may be of benefit to HCC patients. Because angiogenesis plays an important role in recurrence of HCC after resection, antiangiogenic therapy is beneficial to HCC patients following surgical resection of the tumor.

1 January 2010 in World Journal of Gastroenterology
Verified
Journal Article
Open access
XWXiong-Zhi Wu
Xiong-Zhi Wu
FMFeng Ma
Feng Ma
XWXue-Lin Wang
Xue-Lin Wang
To investigate the serological diagnostic factors for liver metastasis in patients with colorectal cancer. One hundred and six adult in-patients with colorectal cancer were studied and divided into patients with liver metastasis (n = 56) and patients without liver metastasis (n = 50). Serum levels of tumor and biochemical markers for liver were measured at the time of diagnosis. The mean survival time was 55.9 mo, 36.8 mo and 68.3 mo for the overall patients, patients with liver metastasis and patients without liver metastasis, respectively. Lactate dehydrogenase (LDH) level was significantly correlated with the survival time of colorectal cancer patients. The levels of alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase (GGT), LDH and carcinoembryonic antigen (CEA) were significantly higher in patients with liver metastasis than in those without liver metastasis. Patients with lymph node metastasis had a higher risk of liver metastasis than those without lymph node metastasis. The cut points of LDH, GGT and CEA for screening liver metastasis were 180 U/L, 30 U/L and 5.0 microg/L, respectively. The sensitivity was 64.3%, 69.6% and 70.4%, and the specificity was 64.0%, 60.0% and 52.4%, respectively. The sensitivity of parallel test was 85.2% for LDH and CEA, and 92.6% for GGT and CEA, respectively. The specificity of serial test was 85.7% for LDH (or GGT) and CEA. Early diagnosis of liver metastasis is of great significance. The sensitivity and specificity of combined tumor and biochemical markers are rather good in screening colorectal liver metastasis.

16 June 2006 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
XWXiong-Zhi Wu
Xiong-Zhi Wu
DCDan Chen
Dan Chen

28 November 2007 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
XWXiong-Zhi Wu
Xiong-Zhi Wu

1 January 2006 in Medical Hypotheses
Verified
Journal Article
Closed access
XWXiong-Zhi Wu
Xiong-Zhi Wu
DCDan Chen
Dan Chen
GXGuang Ru Xie
Guang Ru Xie

1 January 2013 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CZCong Zhu
Cong Zhu
RCRui Cao
Rui Cao
SZShuang-Xia Zhang
Shuang-Xia Zhang
YMYa-Nan Man
Ya-Nan Man
XWXiong-Zhi Wu
Xiong-Zhi Wu
Some sulphated polysaccharides can bind bFGF but are unable to present bFGF to its high-affinity receptors. Fucoidan, a sulphated polysaccharide purified from brown algae, which has been used as an anticancer drug in traditional Chinese medicine for hundreds of years, exhibits a variety of anticancer effects, including the induction of the apoptosis and autophagy of cancer cells, the inhibition of the growth of cancer cells, the induction of angiogenesis, and the improvement of antitumour immunity. Our research shows that fucoidan dose not inhibit the expressions of VEGF, bFGF, IL-8, and heparanase in HCC cells and/or tumour tissues. Moreover, fucoidan exhibited low affinity for bFGF and could not block the binding of bFGF to heparan sulphated. Although fucoidan had no effect on angiogenesis and apoptosisin vivo, this drug significantly inhibited the tumour growth and the expression of PCNA. These results suggest that fucoidan exhibits an anticancer effectin vivoat least partly through inhibition of the proliferation of HCC cells, although it is unable to suppress the angiogenesis induced by HCC.